Time to publication for NIHR HTA programme-funded research: a cohort study
Fay Chinnery1, Amanda Young, Jennie Goodman
1National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre (NETSCC), University of Southampton, Southampton, Hants, UK.
BMJ Open
|November 29, 2013
Summary
National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research publishes promptly. HTA monographs are published 9 months faster than external journal articles, highlighting the value of HTA publications.
Area of Science:
- Health Services Research
- Biomedical Publication
- Health Technology Assessment
Background:
- Timely dissemination of research findings is crucial for evidence-based healthcare decisions.
- The National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme funds a significant volume of health research.
- Understanding publication timelines is essential for assessing research impact and efficiency.
Purpose of the Study:
- To evaluate the time to publication for primary research and evidence syntheses funded by the NIHR HTA Programme.
- To compare publication times for monographs in Health Technology Assessment versus journal articles in the broader biomedical literature.
Main Methods:
- Retrospective cohort study design.
- Inclusion of HTA Programme-funded projects registered by a specific date.
- Analysis of publication timelines using NIHR databases and the HTA Programme website.
Main Results:
- Median publication time for primary research was 23 months (26.5 months for monograph, 35.5 months for journal).
- Median publication time for evidence syntheses was 25.5 months (28 months for monograph).
- 69% of primary research and 65% of evidence syntheses were published within 30 months.
Conclusions:
- Research funded by the NIHR HTA Programme demonstrates prompt publication.
- Publication as an HTA monograph is significantly faster than as an external journal article, underscoring the value of the HTA publication route.
Keywords:
STATISTICS & RESEARCH METHODSMore Related Videos
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
252
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
252
Study Designs in Epidemiology
1.7K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.7K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Longitudinal Research
11.7K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.7K
Hazard Ratio
785
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
785


